- English (UK)
- English (India)
- English (Canada)
- English (Australia)
- English (South Africa)
- English (Philippines)
- English (Nigeria)
- Deutsch
- Español (España)
- Español (México)
- Français
- Italiano
- Nederlands
- Polski
- Português (Portugal)
- Português (Brasil)
- Русский
- Türkçe
- العربية
- Ελληνικά
- Svenska
- Suomi
- עברית
- 日本語
- 한국어
- 简体中文
- 繁體中文
- Bahasa Indonesia
- Bahasa Melayu
- ไทย
- Tiếng Việt
- हिंदी
Lineage Cell Therapeutics Inc (LCTX)
2.87
+0.06(+2.14%)
After Hours
2.88
+0.01(+0.3484%)
- Real-time Data
- Volume:1,081,997
- Bid/Ask:2.87/2.95
- Day's Range:2.805 - 2.92
LCTX Overview
- Prev. Close
- 2.81
- Day's Range
- 2.805-2.92
- Revenue
- 1.7M
- Open
- 2.84
- 52 wk Range
- 0.73-3.1316
- EPS
- -0.09
- Volume
- 1,081,997
- Market Cap
- 465.35M
- Dividend (Yield)
- N/A(N/A)
- Average Vol. (3m)
- 1,183,061
- P/E Ratio
- -
- Beta
- 1.88
- 1-Year Change
- 187.37%
- Shares Outstanding
- 162,141,197
- Next Earnings Date
- Aug 12, 2021
What is your sentiment on Lineage Cell Therapeutics Inc?
or
Market is currently closed. Voting is open during market hours.
Lineage Cell Therapeutics Inc News
- AMD, BA, VALE among premarket gainers
- BySeeking Alpha-
Co-Diagnostics (NASDAQ:CODX) +176% on eliminating debt.Eyenovia (NASDAQ:EYEN) +52% on positive MicroStat data.Ekso Bionics Holdings (NASDAQ:EKSO) +33% on $100M JV to develop the...
- Acorda down 12% on Goldman cut in premarket analyst action
- BySeeking Alpha-
Novavax (NASDAQ:NVAX) initiated with Outperform rating and $4 (87% upside) price target at Oppenheimer. Shares up 3% premarket.Synthetic Biologics (NYSEMKT:SYN) initiated with...
Lineage Cell Therapeutics Inc Analysis
- Lineage Cell Therapeutics Sees Hammer Chart Pattern: Time To Buy?
Lineage Cell Therapeutics, Inc. (NYSE:LCTX) has been struggling lately, but the selling pressure may be coming to an end soon. That is because LCTX recently saw a Hammer Chart...
- Aytu BioScience (AYTU) In Focus: Stock Moves 6.4% Higher
Aytu BioScience, Inc. (NASDAQ:AYTU) was a big mover last session, as the company saw its shares rise more than 6% on the day. The move came on solid volume too with far more...
- BioTime, Inc. (BTX) Looks Good: Stock Adds 6% In Session
BioTime, Inc. (NYSE:BTX) was a big mover last session, as the company saw its shares rise 6% on the day. The move came on solid volume too with far more shares changing hands...
Technical Summary
Type | 5 Min | 15 Min | Hourly | Daily | Monthly |
|---|---|---|---|---|---|
| Moving Averages | Strong Buy | Strong Buy | Buy | Strong Buy | Strong Buy |
| Technical Indicators | Buy | Sell | Strong Buy | Strong Buy | Strong Buy |
| Summary | Strong Buy | Neutral | Strong Buy | Strong Buy | Strong Buy |
Trending Stocks
Trending Stocks
Name | Last | High | Low | Chg. | Chg. % | Vol. | Time | ||
|---|---|---|---|---|---|---|---|---|---|
| 2,430.20 | 2,441.72 | 2,418.96 | -4.93 | -0.20% | 1.10M | NASDAQ | |||
| 331.26 | 332.83 | 328.93 | -1.20 | -0.36% | 13.59M | NASDAQ | |||
| 211.64 | 213.46 | 211.00 | -1.43 | -0.67% | 12.28M | NYSE | |||
| 134.62 | 134.65 | 133.65 | +0.40 | +0.30% | 6.53M | NASDAQ | |||
| 7.25 | 7.31 | 7.12 | -0.29 | -3.91% | 9.89K | OTC Markets | |||
| 63.39 | 63.62 | 62.15 | +1.09 | +1.75% | 2.93M | NASDAQ | |||
| 21.09 | 22.11 | 20.76 | -1.06 | -4.79% | 26.70K | NASDAQ | |||
| 2,513.93 | 2,526.99 | 2,498.29 | -7.67 | -0.30% | 1.26M | NASDAQ | |||
| 29.32 | 29.35 | 29.13 | +0.14 | +0.48% | 31.09M | NYSE | |||
| 57.33 | 57.55 | 57.01 | -0.01 | -0.02% | 12.93M | NYSE | |||
| 187.69 | 190.95 | 186.67 | -2.52 | -1.32% | 3.29M | NASDAQ | |||
| 67.80 | 67.99 | 66.86 | +0.69 | +1.03% | 214.87K | NASDAQ | |||
| 60.50 | 60.63 | 59.87 | +0.20 | +0.33% | 6.98M | NYSE | |||
| 220.70 | 227.92 | 220.03 | -5.03 | -2.23% | 8.73M | NYSE | |||
| 10.14 | 10.14 | 10.04 | +0.02 | +0.25% | 2.47K | NASDAQ |
Lineage Cell Therapeutics Inc Company Profile
Lineage Cell Therapeutics Inc Company Profile
Lineage Cell Therapeutics, Inc. is a clinical-stage biotechnology company. The Company is engaged in developing cell therapies for unmet medical needs. It is focused on developing therapies for degenerative retinal diseases, neurological conditions associated with demyelination and aiding the body in detecting and combating cancer. Specifically, it is testing therapies to treat dry age-related macular degeneration, spinal cord injuries and non-small cell lung cancer. It has three allogeneic cell therapy programs: OpRegen, OPC1 and VAC2. OpRegen is a retinal pigment epithelium cell replacement therapy being developed for the treatment of advanced dry age-related macular degeneration (AMD) with geographic atrophy. OPC1 is an oligodendrocyte progenitor cell therapy that is being developed for acute spinal cord injuries (SCI). VAC2 is a cancer immunotherapy of antigen-presenting dendritic cells that is being developed for non-small cell lung cancer.
Read More
- 2021-06-01 20:21:12
We waited 100 days and went back to 3 usd- 2021-06-06 17:52:32and? Are you holding or selling? What is your pt?
- 2021-06-01 14:41:12why nobody comments this good result?
- 2021-03-29 11:02:10i wait for 5 usd. until 2022
- 2021-03-17 21:11:53dont wait for 3 usd
- 2021-03-02 10:44:41we need another spike to 3$
- 2021-03-11 02:24:39Hello any news from your side?
- 2021-01-31 11:51:24after 7 dsys of declines it is clear ee have been captured by a digital organization of bad people
- 2021-01-31 14:36:52
Why is this?
- 2021-01-26 15:39:47
I can’t find something that will help me understand what was the reason she started to fly- 2021-01-26 17:41:04because it is a good stock to hold long and strong
- 2021-01-21 14:45:00
why is it down- 2021-01-21 15:50:35there does not seem to be a justifiable reason other than the difficulty of getting on without taking air on the way.let's hope for the best
- 2021-01-26 17:36:38difficulty of getting on without taking air on the way.
- 2021-01-19 00:55:40We are really close to $3 but then¿ I seethe avg target price is $5.25 and the highest $7...any thoughts?
- 2020-12-15 19:11:13Hello everybody, any news after the spike to 2.01?Show previous replies (3)
- 2021-01-15 17:07:23שלמה אביבי Hello, what is your tp¿?
- 2021-01-15 20:02:21שלמה אביבי hello, what is your tp?
- 2021-01-26 16:24:18שלמה אביבי hello, any good news coming? I dont understand the big pull back from above the $3
- 2019-01-30 15:26:10Should hae another pump on 2nd Green day here, hey?
- 2019-01-30 03:16:09Strong buy !
- 2019-01-11 06:41:00going long with this
- 2015-10-13 03:35:20Hey
Disclaimer: Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. All derived (stocks, indexes, futures), cryptocurrencies, and Forex prices are not provided by exchanges but rather by market makers, and so prices may not be accurate and may differ from the actual market price, meaning prices are indicative and not appropriate for trading purposes. Therefore Fusion Media doesn't bear any responsibility for any trading losses you might incur as a result of using this data. Fusion Media or anyone involved with Fusion Media will not accept any liability for loss or damage as a result of reliance on the information including data, quotes, charts and buy/sell signals contained within this website. Please be fully informed regarding the risks and costs associated with trading the financial markets, it is one of the riskiest investment forms possible.